MicroRNA (miRNA) expression is deregulated in many tumors including chronic lymphocytic leukemia (CLL). Although the particular mechanism(s) responsible for their aberrant expression is not well characterized, the presence of mutations and single-nucleotide polymorphisms (SNPs) in miRNA genes, possibly affecting their secondary structure and expression, has been described. In CLL; however, the impact and frequency of such variations have yet to be elucidated. Using a custom resequencing microarray, we screened sequence variations in 109 cancer-related pre-miRNAs in 98 CLL patients. Additionally, the primary regions of miR-29b-2/29c and miR-16-1 were analyzed by Sanger sequencing in another cohort of 213 and 193 CLL patients, respectively. Altogether, we describe six novel miR-sequence variations and the presence of SNPs (n = 27), most of which changed the miR-secondary structure. Moreover, some of the identified SNPs have a significantly different frequency in CLL when compared with a control population. Additionally, we identified a novel variation in miR-16-1 that had not been described previously in CLL patients. We show that this variation affects the expression of mature miR-16-1. We also show that the expression of another miRNA with pathogenetic relevance for CLL, namely miR-29b-2, is influenced by the presence of a polymorphic insertion, which is more frequent in CLL than in a control population. Altogether, these data suggest that sequence variations may occur during CLL development and/or progression.

CEITEC Central European Institute of Technology Center of Molecular Medicine Masaryk University Brno 625 00 Czech Republic

Zobrazit více v PubMed

Lewis B.P., et al. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15–20 PubMed

Lim L.P., et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769–773 PubMed

Brennecke J., et al. (2005). Principles of microRNA-target recognition. PLoS Biol., 3, e85. PubMed PMC

Krek A., et al. (2005). Combinatorial microRNA target predictions. Nat. Genet., 37, 495–500 PubMed

Bartel D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281–297 PubMed

Calin G.A., et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA, 99, 15524–15529 PubMed PMC

Klein U., et al. (2010). The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell, 17, 28–40 PubMed

Döhner H., et al. (2000). Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med., 343, 1910–1916 PubMed

Calin G.A., et al. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 353, 1793–1801 PubMed

Mraz M., et al. (2009). miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia, 23, 1159–1163 PubMed

Mraz M., et al. (2012). MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood, 119, 2110–2113 PubMed

Mraz M., et al. (2012). MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. Expert Rev. Hematol., 5, 579–581 PubMed

Mraz M., et al. (2013). MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia. Leuk. Lymphoma, 54, 1836–1839 PubMed PMC

Zenz T., et al. (2009). miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood, 113, 3801–3808 PubMed

Asslaber D., et al. (2010). MicroRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood, 115, 4191–4197 PubMed

Pekarsky Y., et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res., 66, 11590–11593 PubMed

Lu J., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834–838 PubMed

Takamizawa J., et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 64, 3753–3756 PubMed

Calin G.A., et al. (2006). MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857–866 PubMed

Volinia S., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257–2261 PubMed PMC

Duan R., et al. (2007). Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet., 16, 1124–1131 PubMed

Denli A.M., et al. (2004). Processing of primary microRNAs by the microprocessor complex. Nature, 432, 231–235 PubMed

Han J., et al. (2004). The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev., 18, 3016–3027 PubMed PMC

Grishok A., et al. (2001). Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell, 106, 23–34 PubMed

Hutvágner G., et al. (2001). A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science, 293, 834–838 PubMed

Doench J.G., et al. (2004). Specificity of microRNA target selection in translational repression. Genes Dev., 18, 504–511 PubMed PMC

Iwai N., et al. (2005). Polymorphisms in human pre-miRNAs. Biochem. Biophys. Res. Commun., 331, 1439–1444 PubMed

Saunders M.A., et al. (2007). Human polymorphism at microRNAs and microRNA target sites. Proc. Natl Acad. Sci. USA, 104, 3300–3305 PubMed PMC

Landi D., et al. (2008). Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29, 579–584 PubMed

He H., et al. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl Acad. Sci. USA, 102, 19075–19080 PubMed PMC

Chin L.J., et al. (2008). A SNP in a let-7 microRNA complementary site in the KRAS 3’ untranslated region increases non-small cell lung cancer risk. Cancer Res., 68, 8535–8540 PubMed PMC

Wojcik S.E., et al. (2010). Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis, 31, 208–215 PubMed PMC

Mott J.L., et al. (2007). mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene, 26, 6133–6140 PubMed PMC

Santanam U., et al. (2010). Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc. Natl Acad. Sci. USA, 107, 12210–12215 PubMed PMC

Mraz M., et al. (2009). MicroRNA isolation and stability in stored RNA samples. Biochem. Biophys. Res. Commun., 390, 1–4 PubMed

Lipshutz R.J., et al. (1999). High density synthetic oligonucleotide arrays. Nat. Genet., 21(s uppl. 1), 20–24 PubMed

Marshall O.J. (2004). PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics, 20, 2471–2472 PubMed

Cutler D.J., et al. (2001). High-throughput variation detection and genotyping using microarrays. Genome Res., 11, 1913–1925 PubMed PMC

Di X., et al. (2005). Alternative base calling method for resequencing microarrays. Conf. Proc. IEEE Eng. Med. Biol. Soc., 3, 2809–2812 PubMed

Bruce C.K., et al. (2010). Design and validation of a metabolic disorder resequencing microarray (BRUM1). Hum. Mutat., 31, 858–865 PubMed

Consortium G.P. (2010). A map of human genome variation from population-scale sequencing. Nature, 467, 1061–1073 PubMed PMC

Gruber A.R., et al. (2008). The Vienna RNA websuite. Nucleic Acids Res., 36(Web Server issue), W70–W74 PubMed PMC

Moorhead M., et al. (2006). Optimal genotype determination in highly multiplexed SNP data. Eur. J. Hum. Genet., 14, 207–215 PubMed

Zeng Y., et al. (2005). Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J., 24, 138–148 PubMed PMC

Han J., et al. (2006). Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell, 125, 887–901 PubMed

Zeng Y., et al. (2005). Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J. Biol. Chem., 280, 27595–27603 PubMed

Cimmino A., et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944–13949 PubMed PMC

Lujambio A., et al. (2007). CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle, 6, 1455–1459 PubMed

Bandres E., et al. (2009). Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer, 125, 2737–2743 PubMed

Hu Z., et al. (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat., 30, 79–84 PubMed

Xu B., et al. (2010). A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo . Prostate, 70, 467–472 PubMed

Jazdzewski K., et al. (2008). Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl Acad. Sci. USA, 105, 7269–7274 PubMed PMC

Zhou B., et al. (2011). Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol. Carcinog., 50, 499–505 PubMed

Mencía A., et al. (2009). Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat. Genet., 41, 609–613 PubMed

Borel C., et al. (2008). Functional genetic variation of human miRNAs and phenotypic consequences. Mamm. Genome, 19, 503–509 PubMed

Xu T., et al. (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis, 29, 2126–2131 PubMed

Wang F., et al. (2012). miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Mol. Biol. Rep., 39, 2713–2722 PubMed

Li Y., et al. (2009). Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci., 100, 1234–1242 PubMed

Voorhoeve P.M., et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 124, 1169–1181 PubMed

Malcikova J., et al. (2009). Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. Blood, 114, 5307–5314 PubMed

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors

MicroRNAs in B-cell lymphomas: how a complex biology gets more complex